company? Let’s change
that.
Don't see your company?
Create a company profileTrailblazing with the most valuable ingredient in milk, TurtleTree released LF+, the world’s first sustainably produced lactoferrin made using cutting-edge precision fermentation technology. Lactoferrin is a bioactive milk protein that nutritionally enhances not only plant-based foods but every single food product. This process enables animals to live carefree, happier lives. In the long term, TurtleTree will deliver on its ambitious plan to bring cell-based milk to the world.
Titanovo develops a range of digital health tools that include wellness testing kits based on genetics and other biomarkers for results.
Ichor Life Sciences is a premium pre-clinical contract research organization offering services in discovery through pharmacology. The company operates R&D laboratories in LaFayette and Potsdam, New York, including an AAALAC accredited vivarium. Services are provided through two divisions. Ichor Discovery Services provides world-class protein manufacturing, as well as a full suite of capabilities in structural biology, biophysics and assay development. Ichor Pharmacology Services offers in vitro testing, histology, PK/PD, in vivo toxicology and in vivo efficacy capabilities. Therapeutic areas served by Ichor Life Sciences include oncology, metabolic disease, musculoskeletal disease, ophthalmology, and geriatrics. Ichor Life Sciences was founded in 2013 and is headquartered in New York’s Finger Lakes intellectual corridor.
BioAi Health is a leading provider of cutting-edge technologies and services, offering scalable solutions for companies of all sizes. Our platform technology integrates complex data sets from translational studies and clinical trials. We have the capability to develop machine learning models on multi-omic data that can help predict patient response to therapy & drug resistance Founded by a group of friends who started by scribbling their ideas on a piece of paper, today we offer smart, innovative services to dozens of clients worldwide. Our team of experts has a proven track record in developing strategic partnerships with the Pharma industry and solving major challenges in R&D
Agribody Technologies is an ag biotech company that provides solutions for extending produce shelf life while increasing yields.
A stealth medical device company.
La Jolla Pharmaceutical is a biopharmaceutical company that is focused on innovative therapeutics for chronic organ failure and cancer.
Nereus Pharmaceuticals engages in the discovery and development of therapeutics for the treatment of infectious diseases and inflammation.
Vivex Biomedical is a biomedical company developing implant technology and stem cell therapies.
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
Pliant Therapeutics is a late-stage biopharmaceutical company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases. At Pliant, we share a commitment and a clear passion to drive innovative science towards addressing areas of unmet medical need. Together we believe we have the power to make a difference in the lives of patients and those impacted by fibrotic diseases. We believe that by harnessing the therapeutic potential of integrin biology and TGF-β modulation, there is a potential to create drug candidates aimed at halting or even reversing fibrotic diseases. Pliant recognizes the importance of diversity, equity and inclusion initiatives and that they require an evolving and ongoing commitment. Pliant is an equal opportunity employer and does not discriminate against any individual or potential candidate based on race, color, religion, sex, national origin, sexual preference or any other legally protected category. Pliant is located in South San Francisco, California, the birthplace of biotechnology. Proud to be a San Francisco Business Times Best Place to Work in 2023. Learn more about how we are breaking ground in the treatment of fibrotic diseases at www.PliantRx.com.
Gusto Global focuses on restoring key functionalities of a healthy microbiome.
Project Ronin is on a mission to transform cancer care by helping doctors and patients make better-informed decisions about treatment. Our cancer intelligence software provides all the information physicians need, in one place, to assess patient care options and take action. We use predictive technology to present doctors with different scenarios that can help them further optimize care. And, we bring the patient voice to the physician by allowing patients to report symptoms, side effects, and disease progression information via our mobile app, enabling real-time symptom management and true shared decision making with the care team. Project Ronin was founded by Dave Hodgson, one of the world’s leading architects of smart technology for doctors and patients; renowned cancer expert Dr. David Agus; serial health entrepreneur Rowan Chapman, PhD; and tech visionary Larry Ellison. We’re hiring!
Big Data for Water Intensive Industries
At Sony Biotechnology, our flow cytometry and imaging products reflect our full commitment to produce and support high quality, innovative products to support advanced biomedical research. Founded in 1995, we are based in San Jose, California with affiliate offices in Japan, China and Europe. Innovation Research and Development as well as engineering teams are based in Japan. Their innovative approaches and technical know-how is incorporated into our product platforms has been recognized in patents as well as numerous technology and design awards. For example, to improve stability, our systems allow direct monitoring of particle flow status using technology originally developed for the Blu-ray disk that delivers error free performance while operating at very high speed. In conventional flow cytometers, this accuracy largely depends on skillful operators. To deliver very low noise electronics, our systems incorporate technologies that have brought pure, true sound to music. This Sony know-how reduces signal noise from the electric circuit currents to achieve very low noise electronics so that rogue signal noise does not get in the way of delivering accurate results to scientists. Importantly, our innovations also come from looking beyond the conventional made possible by constant sensing and deep study of advanced technologies for superior solutions to customer challenges. Our use of microfluidics and spectral analysis are two examples of this innovative approach to product design and development.
Centricity Research is an integrated research organization (IRO) with more than 40 wholly owned and integrated clinical research offices across North America. The company conducts Phase I-IV clinical research in over 35 therapeutic areas: inpatient and outpatient; pharmaceutical, biotechnology, and medical device trials. For more than 25 years, the organization’s founders have worked to revolutionize research by investing in the people and technology needed to deliver outstanding clinical trial experiences, earning numerous awards including “Best Places to Work” and recognition for “Outstanding Diversity in Clinical Research.” Jobseekers: Apply here >> https://centricityresearch.applytojob.com/apply
Advancing Plant Based Medicine
The Chan Zuckerberg Biohub Network is a group of nonprofit research institutes that bring together physicians, scientists, and engineers with the goal of pursuing grand scientific challenges on 10- to 15-year time horizons. These institutes partner with Chan Zuckerberg Science in its goal to understand the mysteries of the cell and how cells interact within systems. This collaboration will bring us closer to our mission to cure, prevent, or manage all disease by the end of the century. CZ Biohub San Francisco — which was the inaugural Biohub and launched in 2016 — focuses on infectious disease, quantitative cell science, and technology platforms. It also has an investigator program supporting early-stage, risky research of scientists at Stanford University, UC Berkeley, and UCSF. CZ Biohub Chicago, which launched in 2023, focuses on engineering technologies to make precise, molecular-level measurements of biological processes within human tissues, with an ultimate goal of understanding and treating the inflammatory states that underlie many diseases. It is a collaboration between the University of Chicago, Northwestern University, and the University of Illinois Urbana-Champaign.
PhenoTech a biotechnology company, engages in the discovery, development, and commercialization of reagents for diagnostic.
Miromatrix Medical is engaged in the development of fully biological human organs and organ-derived biological products.